268 related articles for article (PubMed ID: 30819087)
1. Dysregulated Interleukin -33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's Thyroiditis.
Wang X; Shao X; Liu X; Qin Q; Xu J; Zhang JA
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1012-1021. PubMed ID: 30819087
[TBL] [Abstract][Full Text] [Related]
2. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
[TBL] [Abstract][Full Text] [Related]
3. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto's thyroiditis compared to non-autoimmune thyroid disease and healthy controls.
Ruggeri RM; Minciullo P; Saitta S; Giovinazzo S; Certo R; Campennì A; Trimarchi F; Gangemi S; Benvenga S
Hormones (Athens); 2014; 13(3):338-44. PubMed ID: 25079457
[TBL] [Abstract][Full Text] [Related]
5. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.
Song RH; Yu ZY; Qin Q; Wang X; Muhali FS; Shi LF; Jiang WJ; Xiao L; Li DF; Zhang JA
Int J Clin Exp Pathol; 2014; 7(7):4024-31. PubMed ID: 25120780
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of ST2-IL18R1-IL18RAP gene cluster: a new risk for autoimmune thyroid diseases.
Wang X; Zhu YF; Li DM; Qin Q; Wang Q; Muhali FS; Jiang WJ; Zhang JA
Int J Immunogenet; 2016 Feb; 43(1):18-24. PubMed ID: 26566691
[TBL] [Abstract][Full Text] [Related]
7. A higher frequency of circulating IL-22(+)CD4(+) T cells in Chinese patients with newly diagnosed Hashimoto's thyroiditis.
Guo H; Peng D; Yang XG; Wang Y; Xu BC; Ni JS; Meng W; Jiang YF
PLoS One; 2014; 9(1):e84545. PubMed ID: 24404171
[TBL] [Abstract][Full Text] [Related]
8. Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto's Thyroiditis.
Peng H; Ding X; Xu J; Han Y; Yang J; Tang X; Wang S; Liu Y
J Immunol Res; 2021; 2021():3577011. PubMed ID: 34869781
[TBL] [Abstract][Full Text] [Related]
9. Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1β in Hashimoto's thyroiditis but not in Graves' disease.
Zake T; Skuja S; Kalere I; Konrade I; Groma V
Endocr J; 2019 May; 66(5):423-430. PubMed ID: 30814438
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.
Sun Z; Chang B; Huang A; Hao S; Gao M; Sun Y; Shi M; Jin L; Zhang W; Zhao J; Teng G; Han L; Tian H; Liang Q; Zhang JY; Zou Z
J Cell Mol Med; 2019 Feb; 23(2):887-897. PubMed ID: 30478965
[TBL] [Abstract][Full Text] [Related]
11. Circulating Th17 cytokine levels are altered in Hashimoto's thyroiditis.
Konca Degertekin C; Aktas Yilmaz B; Balos Toruner F; Kalkanci A; Turhan Iyidir O; Fidan I; Yesilyurt E; Cakır N; Kustimur S; Arslan M
Cytokine; 2016 Apr; 80():13-7. PubMed ID: 26928603
[TBL] [Abstract][Full Text] [Related]
12. Elevated MicroRNA-326 Levels Regulate the IL-23/IL-23R/Th17 Cell Axis in Hashimoto's Thyroiditis by Targeting a Disintegrin and Metalloprotease 17.
Liu Y; Cui X; Wang S; Liu J; Zhao N; Huang M; Qin J; Li Y; Shan Z; Teng W
Thyroid; 2020 Sep; 30(9):1327-1337. PubMed ID: 32204685
[No Abstract] [Full Text] [Related]
13. Increased serum levels of IL-33 and soluble ST2 in neonates with human cytomegalovirus infection.
Chen Y; Qian J
J Med Virol; 2018 Aug; 90(8):1383-1388. PubMed ID: 29663450
[TBL] [Abstract][Full Text] [Related]
14. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
[TBL] [Abstract][Full Text] [Related]
15. IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells.
Zhang Y; Zhang C; Zhuang R; Ma Y; Zhang Y; Yi J; Yang A; Jin B
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003514. PubMed ID: 25658420
[TBL] [Abstract][Full Text] [Related]
16. Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population.
Mbarik M; Kaabachi W; Henidi B; Sassi FH; Hamzaoui K
Immunol Lett; 2015 Jul; 166(1):1-5. PubMed ID: 25977120
[TBL] [Abstract][Full Text] [Related]
17. The IL33/ST2 axis in Sjogren syndrome in relation to disease activity.
Margiotta DP; Navarini L; Vadacca M; Lo Vullo M; Pignataro F; Basta F; Afeltra A
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1295-9. PubMed ID: 27097949
[TBL] [Abstract][Full Text] [Related]
18. Role of interlekin-35 as a biomarker in patients with newly diagnosed Hashimoto's thyroiditis.
Yilmaz H; Cakmak M; Ceydilek B; Demir C; Aktas A
Endocr Regul; 2016 Apr; 50(2):55-61. PubMed ID: 27560637
[TBL] [Abstract][Full Text] [Related]
19. Elevated interleukin-1β in peripheral blood mononuclear cells contributes to the pathogenesis of autoimmune thyroid diseases, especially of Hashimoto thyroiditis.
Sun L; Zhang X; Dai F; Shen J; Ren C; Zuo C; Zhang Q
Endocr Res; 2016 Aug; 41(3):185-92. PubMed ID: 26864865
[TBL] [Abstract][Full Text] [Related]
20. Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis.
Ruggeri RM; Cristani M; Vicchio TM; Alibrandi A; Giovinazzo S; Saija A; Campennì A; Trimarchi F; Gangemi S
J Endocrinol Invest; 2019 Feb; 42(2):199-205. PubMed ID: 29796799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
